FGEN Competitors & Alternatives
Compare FibroGen Inc with similar stocks in the same industry
Biotechnology
FGEN
Main Stock$9.71
Tradestie Score
59
Market Cap
$48.63M
Revenue Growth
7.7%
Analyst Upside
+342.8%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.90
|
$133.50M | - | 57 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.05
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
TPIC
TPIC
|
- | - | - | - | Compare |
|
AFMD
AFMD
|
- | - | - | - | Compare |
|
MEIP
MEIP
|
- | - | - | 49 | Compare |
More FGEN Analysis
Data updated: Jul 02, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry